Infectious Diseases Related News
Tackling AMR and preventing the next global pandemic
The COVID-19 pandemic has highlighted the seriousness of not being prepared for pandemics. With the rise of antimicrobial resistance (AMR), it is thought another...
Plastic face shields do not protect from aerosols, study finds
New research has shown that surgical face masks are as effective at protecting from aerosols as respirators, but plastic face shields offer little or...
Over 2 million people in England may have had long COVID
New research from the largest studies of COVID-19 shows that over 2 million people may have had long COVID.
The findings from the REACT-2 studies...
Post-COVID syndrome: after the pandemic, the pulmonary consequences
Digital ultrasonic spirometry is a new clinical solution perfectly suited to acute and chronic COVID-19 management.
Pulmonary fibrosis is caused by lung inflammation such as...
Certified, high-quality PPE for healthcare professionals
ASAP Innovations represents the healthcare PPE provider of choice – credible, reliable, and most importantly, certified.
ASAP Innovations is a leading manufacturer of medical PPE...
UVC disinfection in indoor spaces
Dr Dorit Aviv of the University of Pennsylvania and Dr Jovan Pantelic of KU Leuven tell HEQ about optimising space design to incorporate UVC...
Holiday essentials to keep you safe
Zidac’s team of experts recommend four key items to take with you to stay safe on your summer holiday.
With summer holidays quickly approaching, many...
Infection control efforts could be hindered by asymptomatic malaria
People infected with malaria who do not exhibit symptoms pose a hidden risk to infection control efforts, new research has shown.
Researchers from the Infectious...
Collecting saliva in a tube to test for COVID-19
The Norwegian municipality of Trondheim will be the first in the country to test for coronavirus by collecting saliva in a tube.
Trondheim in Norway...
Dry surface biofilms: a new layer of defence for superbugs
Emerging research shows traditional disinfectants may not be able to wipe out antibiotic-resistant organisms.
On any given day, one in 18 patients in a European...
50% increase in COVID-19 infections since May, REACT-1 report confirms
The latest REACT-1 report looking into COVID-19 infections in England has shown a 50% increase since the last study in May of this year,...
Common cold can help combat COVID-19 infection
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect from the virus which causes COVID-19, research has found.
A new...
The future of UVC disinfection
University of Siena Associate Professor of Public Health Gabriele Messina speaks with HEQ about innovation in UVC disinfection technology.
The past year has seen an...
Gene could offer protection from severe COVID-19
A new genetic discovery could explain why certain people do not exhibit symptoms of COVID-19, despite being infected with the virus.
A team of scientific...
Prior COVID-19 infection reduces reinfection risk for up to 10 months
People are less likely to be reinfected with COVID-19 if they already contracted the virus within ten months previously, a new study has found.
The...
Possible dog-to-human transmission of new coronavirus
Researchers have uncovered a new coronavirus that has jumped from a dog to a human.
Discovered in a child with pneumonia in Malaysia in 2018,...
Confirmation of strong link between hormones and COVID-19
The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19.
In a new statement, ESE...
World’s first COVID-19 vaccine booster clinical trial begins
The world’s first clinical trial looking at seven different COVID-19 booster vaccines has begun in the UK, with initial results expected in September.
As part...
Nanofibre filter captures 99.9% of coronavirus aerosol
A new study has shown that nanofibre filters capture nearly 100% of coronavirus aerosols – a finding that could help mitigate airborne spread of...
Improving COVID-19 patient outcomes with monoclonal antibodies
A study in the US has concluded that a COVID-19 monoclonal antibodies treatment significantly mitigates the risk of hospitalisation and death from the disease.
The...